Loading organizations...

§ Private Profile · Stockholm, Stockholms Lan, Sweden
Tandem Health is a technology company.
Tandem delivers an AI-driven platform automating complex medication access for healthcare providers. This solution streamlines prior authorizations, appeal letters, and pharmacy communications, integrating with electronic health record systems. Tandem ensures patients receive prescribed therapies faster by navigating approvals and identifying affordable access paths, including financial assistance, thereby optimizing administrative workflows.
Sahir Jaggi founded Tandem, recognizing the significant administrative burden healthcare practices faced securing medication approvals. His insight focused on freeing clinical staff from paperwork and calls to prioritize patient care. This vision aimed to accelerate the crucial transition from prescription to effective treatment, enhancing healthcare efficiency.
Tandem serves healthcare providers by reducing operational strain, and benefits patients through expedited therapy initiation. The company’s vision is to establish an efficient and equitable medication access system. Offering its services free to both providers and patients, Tandem strives to eliminate bureaucratic and financial barriers, fostering a more accessible and patient-focused healthcare ecosystem.
Tandem Health has raised $60.0M across 2 funding rounds.
Tandem Health has raised $60.0M in total across 2 funding rounds.
Tandem Health has raised $60.0M across 2 funding rounds. Most recently, it raised $50.0M Series A in June 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2025 | $50M Series A | Kinnevik | Northzone, Amino Collective | Announced |
| Jun 1, 2024 | $10M Seed | — | Kinnevik, Northzone | Announced |
Tandem Health has raised $60.0M in total across 2 funding rounds.
Tandem Health's investors include Kinnevik, Northzone, Amino Collective.
Tandem Health is a Swedish healthtech company founded in 2023 that builds an AI-powered medical scribe and clinician co-pilot to automate clinical documentation and reduce administrative burdens for healthcare providers.[1][2][3][4] Its core product listens to patient consultations, transcribes them using speech recognition and fine-tuned LLMs, generates draft notes with clinical coding, and integrates seamlessly into over 50 electronic health record (EHR) systems across Europe, supporting 50+ languages and specialties like primary care, mental health, dentistry, and physiotherapy.[1][3][4] Serving over 1,000 healthcare organizations and tens of thousands of clinicians in 11 countries—including a partnership with Accurx reaching 200,000 NHS professionals in the UK—the platform has generated 2.2 million notes, capturing 0.2% of European patient encounters while ensuring CE-marked, GDPR-compliant, and MHRA-registered operations.[1][2][3][4][5] In late 2025, it raised $50M (€40M) in Series A funding led by Kinnevik, with Northzone and others, to expand into a full AI-native operating system for workflows like care coordination and decision support.[2][3]
The company addresses clinicians spending ~40% of time on admin amid clinician shortages and aging populations, enabling more patient-focused care with faster, accurate notes and one-click EHR transfers.[3][4] Growth is rapid: from startup two years prior to widespread adoption, high clinician satisfaction (e.g., 100% at some UK surgeries), and plans to double UK staff for 98% GP penetration.[1][5]
Tandem Health was founded in 2023 in Sweden by CEO and co-founder Lukas Saari, alongside a team where over 80% are clinicians (excluding tech staff), blending AI expertise with deep medical knowledge.[1][3][7] Key advisors include Björn Zoega, former CEO of Karolinska University Hospital, and medical operations leads like Dr. Daniele Rodolico (Italy) and Dr. Oliver Sjögren (Norway).[7] The idea emerged to tackle excessive admin time in healthcare—evident from global strains like rising costs and shortages—by creating a trusted AI scribe that starts with recording consultations, transcribes via speech-to-text and LLMs, and auto-generates compliant notes.[1][3]
Early traction built quickly: within two years, it produced 2.2 million notes, integrated with 50+ EHRs (out of ~500 in Europe), and expanded to 11 countries with local operations in Nordics, UK, France, Spain, Germany, Italy, Estonia, and Netherlands.[1][7] Pivotal moments include the Accurx partnership for NHS scale and the 2025 Series A, fueling European dominance as Europe's leading medical AI co-pilot.[2][3][5]
(Note: A separate U.S.-focused "Tandem" at withtandem.com automates prior authorizations/pharmacy routing, but lacks overlap with this Europe's Tandem Health.[8])
Tandem rides the AI-in-healthcare wave, specifically ambient clinical documentation and LLM-driven workflow automation, amid global pressures like clinician burnout (40% admin time), shortages, and aging demographics straining systems.[2][3] Timing is ideal in the "LLM era," where AI scribes are becoming standard—clinicians won't revert—and Europe's fragmented markets (500+ EHRs, multilingual) demand localized, compliant tools Tandem excels at via 11-country ops.[1][2][3] Market forces favor it: regulatory approvals (CE/MHRA), NHS partnerships, and €40M funding accelerate amid €50B+ European healthtech investment trends.
It influences the ecosystem by normalizing AI copilots, enabling "AI-native" care (e.g., point-of-care decisions), and setting trust benchmarks—pioneering large-scale deployments like UK's NHS rollout, inspiring U.S./global adoption while prioritizing safety over hype.[2][5][6]
Tandem is primed to dominate Europe's AI healthtech as the go-to co-pilot, expanding from scribe to comprehensive OS with coding, coordination, and decision tools—targeting full workflow transformation.[2][3] Key trends like AI regulation maturation, LLM advances, and telehealth growth will propel it, especially in NHS secondary/private care and beyond Europe.[5] Influence may evolve to global leader, potentially via U.S. entry, as it scales to 98% UK GPs and leverages clinician-led trust for sticky adoption.[5] Returning to its core: by reclaiming patient time, Tandem exemplifies AI's potential to humanize overburdened healthcare.[1][3]